Hurley Capital’s GE HealthCare GEHC Stock Holding History

Hurley Capital’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10	Closed	-$751	–	660
2025 Q3	$751	Sell	10 -123	-92%	-$9.17K	﹤0.01%	559
2025 Q2	$9.85K	Buy	133 +132	+13,200%	+$9.19K	0.01%	313
2025 Q1	$81	Buy	+1	New	+$86	﹤0.01%	489

Other funds holding GEHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Hurley Capital's GEHC Position: Q4 2025 in Review

Hurley Capital sold out of GE HealthCare (GEHC) in Q4 2025, closing a stake of 10 shares — an estimated $751 sold.

Hurley Capital first reported a position in GEHC in Q1 2025 and held it in 3 quarters. The position peaked at $9.85K in Q2 2025. 1,335 funds tracked by Wall St. Rank hold GEHC as of Q4 2025.

Hurley Capital reported no remaining GE HealthCare position as of Q4 2025 after selling out during the quarter.
Hurley Capital sold 10 GE HealthCare shares in Q4 2025, an estimated $751.
Hurley Capital first reported a position in GE HealthCare in Q1 2025 and held it in 3 quarters.
Hurley Capital's GE HealthCare position peaked at $9.85K in Q2 2025.
1,335 funds tracked by Wall St. Rank held GE HealthCare as of Q4 2025.

Based on Hurley Capital's 13F filing for Q4 2025, filed 17 Feb 2026.